Medicare Enrolled

Dr. Samerah Razuman, M.D.

Nephrology · Fort Pierce, FL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
2000 HARTMAN RD STE 1, Fort Pierce, FL 34947
7724651170
In practice since 2006 (19 years)
NPI: 1184672164 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Razuman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Razuman? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Razuman

Dr. Samerah Razuman is a nephrology specialist in Fort Pierce, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Razuman performed 3,809 Medicare services across 1,629 unique beneficiaries.

Between the years covered by Open Payments, Dr. Razuman received a total of $8,223 from 39 pharmaceutical and/or device companies across 319 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nephrology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Razuman is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 9% volume in FL $8,223 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,809
Medicare services
Top 9% in FL for nephrology
1,629
Unique beneficiaries
$106
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~200 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, high complexity 1,278 $97 $233
Office visit, established patient (30-39 min) 665 $76 $260
Initial hospital admission, high complexity 305 $137 $378
Dialysis services, 4 or more physician visits per month (20 years or older) 215 $275 $723
Home dialysis services per month (20 years or older) 184 $224 $600
Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes 177 $31 $54
Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month 135 $48 $88
Remote patient monitoring management, 20 min/month 129 $38 $67
Principal care management services for a single high-risk disease, each additional 30 minutes of clinical staff time directed by health care professional, per calendar month 124 $38 $65
Hospital follow-up visit, moderate complexity 114 $64 $153
Dialysis services, 2-3 physician visits per month (20 years or older) 107 $233 $601
Remote patient monitoring device, 30 days 88 $38 $66
Critical care, first 30-74 min 85 $176 $447
New patient office visit (45-59 min) 61 $125 $342
Drug injection, under skin or into muscle 32 $11 $28
Dialysis procedure including 1 evaluation 30 $69 $174
Office visit, established patient (20-29 min) 19 $56 $184
Office visit, established patient, complex (40-54 min) 18 $124 $367
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less 16 $51 $153
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour 16 $16 $42
Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit 11 $151 $390
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.8% high complexity
14.9% medium
84.2% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$8,223
Total received (2018-2024)
Avg $1,175/year across 7 years
Top 10% in FL for nephrology
39
Companies
319
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,029 (97.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$194 (2.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,978
2023
$1,736
2022
$1,816
2021
$1,529
2020
$181
2019
$400
2018
$583

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$1,077
Amgen Inc.
$1,003
Bayer Healthcare Pharmaceuticals Inc.
$852
Bayer HealthCare Pharmaceuticals Inc.
$636
Mallinckrodt Hospital Products Inc.
$581
Vifor Pharma, Inc.
$463
CALLIDITAS THERAPEUTICS US INC.
$325
Ardelyx, Inc.
$299
Takeda Pharmaceuticals U.S.A., Inc.
$258
Otsuka America Pharmaceutical, Inc.
$252
Fresenius USA Marketing, Inc.
$240
Baxter Healthcare
$215
AKEBIA THERAPEUTICS INC
$211
Aurinia Pharma U.S., Inc.
$194
Novo Nordisk Inc
$153
Horizon Therapeutics plc
$148
AMAG Pharmaceuticals, Inc.
$142
Relypsa, Inc.
$129
NxStage Medical, Inc.
$120
OPKO Pharmaceuticals, LLC
$118
Travere Therapeutics, Inc.
$96
GENZYME CORPORATION
$88
Calliditas Therapeutics US Inc.
$66
Keryx Biopharmaceuticals, Inc.
$61
ANI Pharmaceuticals, Inc.
$60
Coala Life Inc
$56
Lilly USA, LLC
$55
Shire North American Group Inc
$54
Mallinckrodt LLC
$52
GlaxoSmithKline, LLC.
$34
Horizon Pharma plc
$29
Alnylam Pharmaceuticals Inc.
$28
Daiichi Sankyo Inc.
$24
Novartis Pharmaceuticals Corporation
$22
Boehringer Ingelheim Pharmaceuticals, Inc.
$19
Medtronic, Inc.
$19
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$16
Alexion Pharmaceuticals, Inc.
$15
Ultragenyx Pharmaceutical Inc.
$12
Top 3 companies account for 35.7% of total payments
Associated products mentioned in payments ›
ACTHAR · AURYXIA · Aranesp · Auryxia · BENLYSTA · BRILINTA · Coala Heart Monitor · Dialyzers · ELLIPSYS VASCULAR ACCESS SYSTEM · EVUSHELD · FABRAZYME · FABRY-DISEASE · FARXIGA · FERAHEME · GATTEX · IBSRELA · INJECTAFER · JARDIANCE · JYNARQUE · KRYSTEXXA · Kerendia · LIBERTY SELECT CYCLER · LOKELMA · LUPKYNIS · NATPARA · Not Product Related · OXLUMO · Ozempic · PURIFIED CORTROPHIN GEL · Parsabiv · Rayaldee · Renal - Extraneal Solution · Renal - PD · SOLIRIS · TARPEYO · TAVNEOS · TERLIVAZ · Tavneos · Tresiba · Uloric · Vafseo · Velphoro · Veltassa · XIFAXAN · XPHOZAH 30 MG
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 10% for nephrology in FL.

Equivalent to $216 per 100 Medicare services performed
Looking for a nephrology specialist in Fort Pierce?
Compare nephrologists in the Fort Pierce area by procedure volume, costs, and industry payment transparency.
Browse nephrologists nearby

Geographic Context

Nephrologists within 10 mi
23
Per 100K population
6.6
County median income
$69,027
Nearest hospital
HCA FLORIDA LAWNWOOD HOSPITAL
2.8 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Razuman is a clinical cardiology specialist, with above-average Medicare volume (top 9% in FL), with low-engagement industry engagement in the top 10% of FL peers, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Razuman experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Razuman performed 1,278 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Razuman receive payments from pharmaceutical companies?
Yes. Dr. Razuman received a total of $8,223 from 39 companies across 319 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Razuman's costs compare to other nephrologists in Fort Pierce?
Dr. Razuman's average Medicare payment per service is $106. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Razuman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →